A carregar...

Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan

BACKGROUND: The coronavirus disease 2019 (COVID‐19) pandemic has resulted in millions of deaths and overburdened healthcare systems worldwide. Systemic low‐dose corticosteroids have proven clinical benefit in patients with severe COVID‐19. Higher doses of corticosteroids are used in other inflammato...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Anaesthesiol Scand
Main Authors: Munch, MW, Granholm, Anders, Myatra, SN, Vijayaraghavan, BKT, Cronhjort, Maria, Wahlin, RR, Jakob, Stephan M., Cioccari, Luca, Kjær, MN, Vesterlund, GK, Meyhoff, TS, Helleberg, Marie, Møller, MH, Benfield, Thomas, Venkatesh, Balasubramanian, Hammond, Naomi, Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Vivekanand, Kristiansen, KT, Ulrik, CS, Jørgensen, VL, Smitt, Margit, Bestle, Morten H., Andreasen, AS, Poulsen, LM, Rasmussen, BS, Brøchner, AC, Strøm, Thomas, Møller, Anders, Khan, MS, Padmanaban, Ajay, Divatia, JV, Saseedharan, Sanjith, Borawake, Kapil, Kapadia, Farhad, Dixit, Subhal, Chawla, Rajesh, Shukla, Urvi, Amin, Pravin, Chew, Michelle S., Gluud, Christian, Lange, Theis, Perner, Anders
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8014264/
https://ncbi.nlm.nih.gov/pubmed/33583034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/aas.13795
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!